About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prediction of Future Risk in Patients With Controlled Asthma

NCT01565031·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Luis Perez de Llano, Md, PhD
CONTACT
34 982296000 eremos26@hotmail.com

Lead

Luis Perez de Llano

With

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Hospital Clinic of Barcelona
Hospital Galdakao-Usansolo
Complexo Hospitalario Universitario de A Coruña

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults (age between 18 and 80.
Asthma under control during the last 3 months.
Treated with a combination of ICS and long-acting beta-agonist (LABA.
Classified as "moderate asthma" by their attending physician.

You may not be if

Active smoking.
Pregnancy.
Treatment with oral corticosteroids, omalizumab or immunotherapy.

The record

StatusUnknown

PhaseNo phase

Taking part338

StartedMay 2012

UpdatedMar 28, 2012

Conditions

Where1

Pneumology Service
Lugo, Lugo, Spain

Clareo Health | Prediction of Future Risk in Patients With Controlled Asthma